These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31231239)

  • 1. Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention.
    Li Z; Wu J; Wei W; Cai X; Yan J; Song J; Wang C; Wang J
    Front Physiol; 2019; 10():686. PubMed ID: 31231239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating mir-483-5p as a novel diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI.
    Zhao Y; Song X; Ma Y; Liu X; Peng Y
    BMC Cardiovasc Disord; 2023 Jul; 23(1):360. PubMed ID: 37464313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-223-5p serves as a diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI.
    Zhang S; Yang G; Chen Y; Liu W
    BMC Cardiovasc Disord; 2024 Aug; 24(1):423. PubMed ID: 39138398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.
    Chen T; Zhang X; Qian W; Zhou R; Su M; Ma Y
    Bioengineered; 2022 Apr; 13(4):8266-8276. PubMed ID: 35302437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients.
    Zhang W; Chang G; Cao L; Ding G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):74. PubMed ID: 33546604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change of serum exosomal miR-186-5p estimates major adverse cardiac events in acute myocardial infarction patients receiving percutaneous coronary intervention.
    Ren L; Liu W; Chen S; Zeng H
    Front Cardiovasc Med; 2024; 11():1341918. PubMed ID: 38694565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction.
    Xu L; Tian L; Yan Z; Wang J; Xue T; Sun Q
    Heart Vessels; 2023 Mar; 38(3):318-331. PubMed ID: 36214846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort.
    Qiao XR; Zheng T; Xie Y; Yao X; Yuan Z; Wu Y; Zhou D; Chen T
    J Transl Med; 2023 May; 21(1):325. PubMed ID: 37189131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome.
    Wang C; Kong Y; Ding Y; Sun J; Chen T
    Med Sci Monit; 2019 Dec; 25():9517-9523. PubMed ID: 31834876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
    Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
    BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
    Jakob P; Kacprowski T; Briand-Schumacher S; Heg D; Klingenberg R; Stähli BE; Jaguszewski M; Rodondi N; Nanchen D; Räber L; Vogt P; Mach F; Windecker S; Völker U; Matter CM; Lüscher TF; Landmesser U
    Eur Heart J; 2017 Feb; 38(7):511-515. PubMed ID: 28011706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dysregulation of plasma miR-497/FGF23 axis, and its association with clinical characteristics and major adverse cardiovascular event in female premature acute coronary syndrome patients.
    Jiang Y; Cai W; Cai G; Wang D; Wu Q
    Ir J Med Sci; 2023 Oct; 192(5):2105-2115. PubMed ID: 36645571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study.
    Gacoń J; Badacz R; Stępień E; Karch I; Enguita FJ; Żmudka K; Przewłocki T; Kabłak-Ziembicka A
    Kardiol Pol; 2018; 76(2):362-369. PubMed ID: 29350392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-26a-5p affects myocardial injury induced by coronary microembolization by modulating HMGA1.
    Kong B; Qin Z; Ye Z; Yang X; Li L; Su Q
    J Cell Biochem; 2019 Jun; 120(6):10756-10766. PubMed ID: 30652345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury].
    Shao A; Qi X; Li Q; Jia W; Wei L; Hou W; Qi Y; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):515-519. PubMed ID: 28625240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
    Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
    Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet miR-107 Participates in Clopidogrel Resistance after PCI Treatment by Regulating P2Y12.
    Zhang Q; Zhu F; Luo Y; Liao J; Cao J; Xue T
    Acta Haematol; 2022; 145(1):46-53. PubMed ID: 34474410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum malondialdehyde-modified low-density lipoprotein levels on admission predict prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Amioka N; Miyoshi T; Otsuka H; Yamada D; Takaishi A; Ueeda M; Hirohata S; Ito H
    J Cardiol; 2019 Sep; 74(3):258-266. PubMed ID: 30898480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.